HIV Post-Exposure Prophylaxis (PEP)

Presenter: Dr. Marianne Harris, MD, CCFP
Clinical Assistant Professor, Department of Family Practice, Faculty of Medicine, University of British Columbia;
Clinical Trials Physician, BC Centre for Excellence in HIV/AIDS.

Share this video:
Scroll to Top

The British Columbia Centre for Excellence in HIV/AIDS Laboratory has discontinued gp-41 resistance testing as T-20 (enfuvirtide/Fuzeon) is no longer available in Canada as of March 31, 2025